Stopping GLP-1 drugs like Ozempic may not always lead to major weight regain, a real-world study finds, highlighting the role of treatment switches and lifestyle changes.
AI chatbots sometimes agree with users expressing delusional or harmful ideas, including suicidal thoughts, raising concerns about how such systems respond to vulnerable users ...
Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte ...
Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...
Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.
ASB GlassFloor, the Swiss manufacturer behind the controversial glass basketball court installed—and then ultimately ...
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
The study also estimated that, in absolute terms, full coverage under the scheme would lift 1.23 crore people out of poverty, reduce the number of extreme poor by 56 lakh, and move 1.56 crore people ...
VinFast owners have reason to feel confident A new study from Vietnam comparing electric and gasoline vehicles suggests EVs may be more durable over time.
Two microscopic grains collide and produce a tiny spark. This phenomenon may have provided the energy to kick off life on Earth. But if these solid particles have the same composition, what factor ...
Transport group Manibela on Friday urged regulators to grant a P1 to P2 provisional fare increase for public utility vehicles (PUVs), saying drivers are ...
The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results